Home  
  Our Team  
  Patient Info  
  Services  
   
  Pay My Bill  
  Contact Us  

News for Healthier Living

Multivariable Screening Tool Outperforms PSA Alone in Detecting Clinically Significant Prostate Cancer

A population-based screening analysis found that Stockholm3, a test that combines prostate-specific antigen (PSA) levels with genetic, protein, and clinical data into a risk score, identified more clinically significant prostate cancers while missing fewer cases than standard PSA screening.

June 22, 2026


June 26 2026

June 25 2026

June 24 2026

June 23 2026

June 22 2026

June 21 2026

June 19 2026

June 18 2026

June 17 2026

June 16 2026

June 15 2026

June 14 2026

June 13 2026